CompletedNot Applicable

Hyperglycemia and Acute Pancreatitis

4,500 participantsStarted 2013-01

Plain-language summary

The goal of this observational study is to learn about post-acute pancreatitis diabetes mellitus (PPDM-A). The main questions it aims to answer are: 1. What are the clinical characteristics of PPDM-A? 2. What are the related factors for PPDM-A? All patients with acute pancreatitis have been given standardized treatment for the condition. The researchers will compare the PPDM-A group with the non-PPDM-A group to find the risk factors for PPDM-A.

Who can participate

Age range18 Years – 80 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients with pancreatitis attending participating centers since January 2013 (patients with clinically reported AP (ICD-10:K85 or related diagnosis));
✓. Age between 18 and 80 years;
✓. Patients have undergone glucose metabolic tests at least 1 month after discharge from hospital.

Exclusion criteria

✕. Patients with a history of diabetes mellitus prior to the AP attack;
✕. Patients who underwent pancreatic surgery;
✕. Patients with hereditary pancreatitis and autoimmune pancreatitis;
✕. Patients with missing data regarding age or gender.

What they're measuring

Number of participants who have developed PPDM-A

Timeframe: From the AP treatment to 5 years after the end of treatment

Trial details

NCT IDNCT06590233

SponsorShanghai Changzheng Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-08

View on ClinicalTrials.gov More Acute Pancreatitis (AP) trials